4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000174
Chairperson & CEO sold 9,500 shares at an average $585.49 ($5,562,190)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-28 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-10-28 | Sale : show line 2 in the form 10b5-1 | −821 | $583.50 | $479,055 | 333,122 | I |
| 2026-10-28 | Sale : show line 3 in the form 10b5-1 | −2,625 | $584.43 | $1,534,132 | 330,497 | I |
| 2026-10-28 | Sale : show line 4 in the form 10b5-1 | −1,902 | $585.36 | $1,113,352 | 328,595 | I |
| 2026-10-28 | Sale : show line 5 in the form 10b5-1 | −3,086 | $586.37 | $1,809,536 | 325,509 | I |
| 2026-10-28 | Sale : show line 6 in the form 10b5-1 | −986 | $587.27 | $579,044 | 324,523 | I |
| 2026-10-28 | Sale : show line 7 in the form 10b5-1 | −80 | $588.39 | $47,071 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $585.49 · $5,562,190 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-28 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option | −9,500 | 138,410 | I |
Loading xslF345X06/primarydocument.xml…